ROCKVILLE Md. Sept. 16 2014 PRNewswire &160;Synthetic Biologics Inc. NYSE MKT SYN a biotechnology company developing novel antiinfective biologic and drug programs targeting specific pathogens that cause serious infections and diseases&160;announce...
↧